BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 8985481)

  • 1. Chromosome 22q11.2 microdeletions in velocardiofacial syndrome patients with widely variable manifestations.
    Ravnan JB; Chen E; Golabi M; Lebo RV
    Am J Med Genet; 1996 Dec; 66(3):250-6. PubMed ID: 8985481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
    Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
    Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the autosomal dominant Optiz GBBB syndrome part of the DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2?
    Wulfsberg EA
    Am J Med Genet; 1996 Aug; 64(3):523-4. PubMed ID: 8862634
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical correlation of chromosome 22q11.2 fluorescent in situ hybridization analysis and velocardiofacial syndrome.
    Oh AK; Workman LA; Wong GB
    Cleft Palate Craniofac J; 2007 Jan; 44(1):62-6. PubMed ID: 17214538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 22q11 deletions in patients with selected outflow tract malformations.
    Frohn-Mulder IM; Wesby Swaay E; Bouwhuis C; Van Hemel JO; Gerritsma E; Niermeyer MF; Hess J
    Genet Couns; 1999; 10(1):35-41. PubMed ID: 10191427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome.
    Driscoll DA; Spinner NB; Budarf ML; McDonald-McGinn DM; Zackai EH; Goldberg RB; Shprintzen RJ; Saal HM; Zonana J; Jones MC
    Am J Med Genet; 1992 Sep; 44(2):261-8. PubMed ID: 1360769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CATCH 22 syndrome: report of 7 infants with follow-up data and review of the recent advancements in the genetic knowledge of the locus 22q11.
    Sergi C; Serpi M; Müller-Navia J; Schnabel PA; Hagl S; Otto HF; Ulmer HE
    Pathologica; 1999 Jun; 91(3):166-72. PubMed ID: 10536461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Otolaryngological manifestations of velocardiofacial syndrome: a retrospective review of 35 patients.
    Ford LC; Sulprizio SL; Rasgon BM
    Laryngoscope; 2000 Mar; 110(3 Pt 1):362-7. PubMed ID: 10718420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of 22q11.2 deletion among 139 patients with Di George/Velocardiofacial syndrome features.
    Kitsiou-Tzeli S; Kolialexi A; Fryssira H; Galla-Voumvouraki A; Salavoura K; Kanariou M; Tsangaris GT; Kanavakis E; Mavrou A
    In Vivo; 2004; 18(5):603-8. PubMed ID: 15523900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11.2.
    Matsuoka R; Takao A; Kimura M; Imamura S; Kondo C; Joh-o K; Ikeda K; Nishibatake M; Ando M; Momma K
    Am J Med Genet; 1994 Nov; 53(3):285-9. PubMed ID: 7856665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Congenital cardiovascular malformations and chromosome microdeletions in 22q11.2].
    Trost D; Engels H; Bauriedel G; Wiebe W; Schwanitz G
    Dtsch Med Wochenschr; 1999 Jan; 124(1-2):3-7. PubMed ID: 9951451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential detection of deletion 22q11.2 syndrome by specialty and indication.
    Katzman PJ; Wang B; Sawhney M; Wang N
    Pediatr Dev Pathol; 2005; 8(5):557-67. PubMed ID: 16222476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical heterogeneity of the chromosome 22q11 microdeletion syndrome].
    Muñoz S; Garay F; Flores I; Heusser F; Talesnik E; Aracena M; Mellado C; Méndez C; Arnaiz P; Repetto G
    Rev Med Chil; 2001 May; 129(5):515-21. PubMed ID: 11464533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Submicroscopic deletions at 22q11.2: variability of the clinical picture and delineation of a commonly deleted region.
    Lindsay EA; Greenberg F; Shaffer LG; Shapira SK; Scambler PJ; Baldini A
    Am J Med Genet; 1995 Mar; 56(2):191-7. PubMed ID: 7625444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and significance of 22q11.2 hemizygosity in patients with interrupted aortic arch.
    Rauch A; Hofbeck M; Leipold G; Klinge J; Trautmann U; Kirsch M; Singer H; Pfeiffer RA
    Am J Med Genet; 1998 Jul; 78(4):322-31. PubMed ID: 9714433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR).
    McQuade L; Christodoulou J; Budarf M; Sachdev R; Wilson M; Emanuel B; Colley A
    Am J Med Genet; 1999 Sep; 86(1):27-33. PubMed ID: 10440825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered replication timing of the HIRA/Tuple1 locus in the DiGeorge and Velocardiofacial syndromes.
    D'Antoni S; Mattina T; Di Mare P; Federico C; Motta S; Saccone S
    Gene; 2004 May; 333():111-9. PubMed ID: 15177686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kabuki syndrome is not caused by a microdeletion in the DiGeorge/velocardiofacial chromosomal region within 22q 11.2.
    Li M; Zackai EH; Niikawa N; Kaplan P; Driscoll DA
    Am J Med Genet; 1996 Oct; 65(2):101-3. PubMed ID: 8911598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes.
    Daw SC; Taylor C; Kraman M; Call K; Mao J; Schuffenhauer S; Meitinger T; Lipson T; Goodship J; Scambler P
    Nat Genet; 1996 Aug; 13(4):458-60. PubMed ID: 8696341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Velo-cardio-facial syndrome and DiGeorge sequence with meningomyelocele and deletions of the 22q11 region.
    Nickel RE; Pillers DA; Merkens M; Magenis RE; Driscoll DA; Emanuel BS; Zonana J
    Am J Med Genet; 1994 Oct; 52(4):445-9. PubMed ID: 7747757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.